Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany
Canopy Growth Corp CGC
News
Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum
Canopy Growth Announces Extension of Proxy Voting Deadline for 2026 Annual General and Special Meeting
Canopy Growth Expands European Medical Cannabis Supply Into the UK
Canopy Growth Reminds Shareholders to Vote Ahead of September 23 Deadline
Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and Formulations
Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote Now
Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows
Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses
Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026
Canopy Growth Announces Participation at Upcoming Canaccord Genuity Growth Conference
The cannabis rescheduling is causing celebration - and confusion - as marijuana stocks sell off
Tilray and other pot stocks soar as Trump is reportedly ready to reclassify cannabis
Canadian Cannabis Stocks Jump on Report U.S. May Move to Reclassify Marijuana
Marijuana stocks sell off as Trump signs executive order to reclassify cannabis
Pot stocks keep blazing after Trump says he's 'very strongly' looking at rescheduling cannabis
Tilray's stock takes off on hope that cannabis will soon be seen as more like steroids than heroin
Cannabis Stocks Rally After Trump Highlights Cannabidiol for Senior Care
United States